.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Colorcon
US Army
Healthtrust
Johnson and Johnson
Dow
Boehringer Ingelheim
Express Scripts
Federal Trade Commission
US Department of Justice

Generated: June 27, 2017

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC ALLERGY Drug Profile

« Back to Dashboard

What is the patent landscape for Children's Zyrtec Allergy, and when can generic versions of Children's Zyrtec Allergy launch?

Children's Zyrtec Allergy is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty-two patent family members in nineteen countries.

The generic ingredient in CHILDREN'S ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty-two suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for Tradename: CHILDREN'S ZYRTEC ALLERGY

Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list49
Clinical Trials: see list6,973
Patent Applications: see list3,755
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHILDREN'S ZYRTEC ALLERGY at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-003Nov 16, 2007DISCNYesNo6,455,533► SubscribeY ► Subscribe
J And J Consumer Inc
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-004Nov 16, 2007DISCNYesNo6,455,533► SubscribeY ► Subscribe
J And J Consumer Inc
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
SYRUP;ORAL022155-002Nov 16, 2007OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CHILDREN'S ZYRTEC ALLERGY

Country Document Number Estimated Expiration
Japan2007091760► Subscribe
Australia727140► Subscribe
Spain2184293► Subscribe
Brazil9810495► Subscribe
New Zealand501820► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CHILDREN'S ZYRTEC ALLERGY

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00085Netherlands► SubscribePRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
01C/045Belgium► SubscribePRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Deloitte
Cerilliant
QuintilesIMS
Queensland Health
Citi
Accenture
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot